Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Cogstate Ltd ( (AU:CGS) ) has provided an announcement.
Cogstate Ltd has announced the issuance of 850,500 fully paid ordinary securities, which will be quoted on the Australian Securities Exchange (ASX) as of July 9, 2025. This move is part of the company’s strategy to enhance its market presence and potentially increase its capital for future growth, signaling a positive step for stakeholders and investors.
The most recent analyst rating on (AU:CGS) stock is a Buy with a A$1.45 price target. To see the full list of analyst forecasts on Cogstate Ltd stock, see the AU:CGS Stock Forecast page.
More about Cogstate Ltd
Cogstate Ltd operates in the healthcare industry, focusing on cognitive science and technology. The company provides cognitive assessment tools and services, primarily targeting clinical trials, academic research, and healthcare markets.
Average Trading Volume: 97,333
Technical Sentiment Signal: Buy
Current Market Cap: A$282.1M
For an in-depth examination of CGS stock, go to TipRanks’ Overview page.